Eight Potential Covid-19 Vaccine Approves For Clinical Trial – W.H.O Announces

Tedros Adhanom Ghebreyesus Director-General of WHO

The World Health Organization (WHO) has announced that 102 potential Covid-19 vaccines are being developed around the world as scientists worldwide find a permanent solution to the novel Coronavirus that has killed hundreds of thousands worldwide and shut down economic life.

According to documents posted on the organization’s website on Thursday, eight of the potential vaccines have been approved for clinical trial.

According to the WHO, China’s vaccine clinical trial request was accepted today as the WHO only had seven vaccine requests four days ago.

Of the groups approved by WHO for clinical trials on humans, four are from China, one is from England, one is American and another is a combined American and European group. No African request has been approved.

According to the WHO, on March 16, the American National Institute of Health (NIH) became the first institute to start testing in human trial subjects.

CORONAVIRUS: Two Coronavirus Vaccine Approved for Human Trial

China has approved early-stage human tests for two experimental coronavirus vaccines as it battles to contain imported cases and prevent a second wave of COVID-19.

The experimental vaccines are being developed by a Beijing-based unit of Sinovac Biotech and by the Wuhan Institute of Biological Products, an affiliate of state-owned China National Pharmaceutical Group, state news agency Xinhua reported on Tuesday.

Al Jazeera’s Sarah Clarke, reporting from Hong Kong, said China’s National Health Commission also confirmed the trials will go ahead.

In March, Beijing gave the green light to another clinical trial for a coronavirus vaccine candidate developed by the military-backed Academy of Military Medical Sciences and biotech firm CanSino Bio, shortly after US drug developer Moderna said it had begun human tests for their vaccine with the US National Institutes of Health.

“We can confirm now that three particular vaccines are being tested in China, and the National Health Commission has said it will have to clear a number of conditions before they can enable mass production of the vaccines globally,” said Clarke.

As of Tuesday, China reported 82,249 coronavirus cases and 3,341 deaths. There were no fatalities over the past 24 hours.